Extranodal NK-T-cell lymphoma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD [2]

Overview

Effective measures for the secondary prevention of extranodal NK-T-cell lymphoma include: LDH , MLH1, PDGFRA, VEGF, PD-L1, PD-1, Cyclin D1, p53, Ki-67

Secondary Prevention

Effective measures for the secondary prevention of extranodal NK-T-cell lymphoma include:^[1]

LDH
MLH1
PDGFRA
VEGF
PD-L1
PD-1
Cyclin D1
p53
Ki-67

References

↑ Zeng, Linshu; Huang, Wenting; Cao, Zheng; Zheng, Bo; Liu, Xiuyun; Guo, Lei; Feng, Xiaoli (2019). “The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage”. Annals of Hematology. 98 (6): 1467–1476. doi:10.1007/s00277-019-03643-9. ISSN 0939-5555.

Template:WH Template:WS

[ZengHuang2019-1] Zeng, Linshu; Huang, Wenting; Cao, Zheng; Zheng, Bo; Liu, Xiuyun; Guo, Lei; Feng, Xiaoli (2019). “The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage”. Annals of Hematology. 98 (6): 1467–1476. doi:10.1007/s00277-019-03643-9. ISSN 0939-5555.

[1]

Extranodal NK-T-cell lymphoma secondary prevention

Overview

Secondary Prevention

References

Looking for the patient version?